Bridgeworth’s Colgate-Palmolive CL Stock Holding History

Bridgeworth’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,858	Closed	-$120K	–	198
2018 Q2	$120K	Buy	+1,858	New	+$122K	0.05%	186

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridgeworth's CL Position: Q3 2018 in Review

Bridgeworth sold out of Colgate-Palmolive (CL) in Q3 2018, closing a stake of 1,858 shares — an estimated $120K sold.

Bridgeworth first reported a position in CL in Q2 2018 and held it in 1 quarter. The position peaked at $120K in Q2 2018. 1,393 funds tracked by Wall St. Rank hold CL as of Q3 2018.

Bridgeworth reported no remaining Colgate-Palmolive position as of Q3 2018 after selling out during the quarter.
Bridgeworth sold 1,858 Colgate-Palmolive shares in Q3 2018, an estimated $120K.
Bridgeworth first reported a position in Colgate-Palmolive in Q2 2018 and held it in 1 quarter.
Bridgeworth's Colgate-Palmolive position peaked at $120K in Q2 2018.
1,393 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2018.

Based on Bridgeworth's 13F filing for Q3 2018, filed 13 Nov 2018.